Association between CDH1 haplotypes and gastric cancer risk in a Japanese population

References

• Hara M, Hanaoka T, Kobayashi M, Otani T, Adachi HY, Montani A, et al. Cruciferous vegetables, mushrooms, and gastrointestinal cancer risks in a multicenter, hospital-based case-control study in Japan. Nutr Cancer 2003; 46: 138–47
   PubMed Web of Science ®Google Scholar
• Machida-Montani A, Sasazuki S, Inoue M, Natsukawa S, Shaura K, Koizumi Y, et al. Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in Japan. Gastric Cancer 2004; 7: 46–53
   PubMedGoogle Scholar
• Shinmura K, Kohno T, Kasai H, Koda K, Sugimura H, Yokota J. Infrequent mutations of the hOGG1 gene, that is involved in the excision of 8-hydroxyguanine in damaged DNA, in human gastric cancer. Jpn J Cancer Res 1998; 89: 825–8
   PubMedGoogle Scholar
• Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H. Interleukin 1α polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002; 123: 92–105
   PubMed Web of Science ®Google Scholar
• Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451–5
   PubMed Web of Science ®Google Scholar
• Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993; 53: 1690–5
   PubMed Web of Science ®Google Scholar
• Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998; 392: 190–3
   PubMed Web of Science ®Google Scholar
• Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 402–5
   PubMed Web of Science ®Google Scholar
• Yoon KA, Ku JL, Yang HK, Kim WH, Park SY, Park JG. Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. J Hum Genet 1999; 44: 177–80
   PubMedGoogle Scholar
• Shinmura K, Kohno T, Takahashi M, Sasaki A, Ochiai A, Guilford P, et al. Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. Carcinogenesis 1999; 20: 1127–31
   PubMedGoogle Scholar
• Humar B, Toro T, Graziano F, Muller H, Dobbie Z, Kwang-Yang H, et al. Novel germline CDH1 mutations in hereditary diffuse gastric cancer families. Hum Mutat 2002; 19: 518–25
   PubMed Web of Science ®Google Scholar
• Wang Y, Song JP, Ikeda M, Shinmura K, Yokota J, Sugimura H. Ile-Leu substitution (I415L) in germline E-cadherin gene (CDH1) in Japanese familial gastric cancer. Jpn J Clin Oncol 2003; 33: 17–20
   PubMedGoogle Scholar
• Oliveira C, de Bruin J, Nabais S, Ligtenberg M, Moutinho C, Nagengast FM, et al. Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour. Oncogene 2004; 23: 2236–40
   PubMed Web of Science ®Google Scholar
• Li LC, Chui RM, Sasaki M, Nakajima K, Perinchery G, Au HC, et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 2000; 60: 873–6
   PubMed Web of Science ®Google Scholar
• Humar B, Graziano F, Cascinu S, Catalano V, Ruzzo AM, Magnani M, et al. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 2002; 21: 8192–5
   PubMed Web of Science ®Google Scholar
• Wu MS, Huang SP, Chang YT, Lin MT, Shun CT, Chang MC, et al. Association of the −160 C –> A promoter polymorphism of E-cadherin gene with gastric carcinoma risk. Cancer 2002; 94: 1443–8
   PubMedGoogle Scholar
• Kuraoka K, Oue N, Yokozaki H, Kitadai Y, Ito R, Nakayama H, et al. Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan. Int J Oncol 2003; 23: 421–7
   PubMedGoogle Scholar
• Lu Y, Xu YC, Shen J, Yu RB, Niu JY, Guo JT, et al. E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population. World J Gastroenterol 2005; 11: 56–60
   PubMedGoogle Scholar
• Park WS, Cho YG, Park JY, Kim CJ, Lee JH, Kim HS, et al. A single nucleotide polymorphism in the E-cadherin gene promoter-160 is not associated with risk of Korean gastric cancer. J Korean Med Sci 2003; 18: 501–4
   PubMedGoogle Scholar
• Pharoah PD, Oliveira C, Machado JC, Keller G, Vogelsang H, Laux H, et al. CDH1 c-160a promoter polymorphism is not associated with risk of stomach cancer. Int J Cancer 2002; 101: 196–7
   PubMedGoogle Scholar
• Dempster AP, Laird NM, Rubin DB. Maximum likelihood estimation from incomplete data via the EM algorithm. J R Stat Soc 1977; 39: 1–38
   Google Scholar
• Tao H, Shinmura K, Hanaoka T, Natsukawa S, Shaura K, Koizumi Y, et al. A novel splice-site variant of the base excision repair gene MYH is associated with production of an aberrant mRNA transcript encoding a truncated MYH protein not localized in the nucleus. Carcinogenesis 2004; 25: 1859–66
   PubMedGoogle Scholar
• Tsukino H, Hanaoka T, Otani T, Iwasaki M, Kobayashi M, Hara M, et al. hOGG1 Ser326Cys polymorphism, interaction with environmental exposures, and gastric cancer risk in Japanese populations. Cancer Sci 2004; 95: 977–83
   PubMed Web of Science ®Google Scholar
• Haiman CA, Stram DO, Pike MC, Kolonel LN, Burtt NP, Altshuler D, et al. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort. Hum Mol Genet 2003; 12: 2679–92
   PubMed Web of Science ®Google Scholar
• Lee KM, Choi JY, Park SK, Chung HW, Ahn B, Yoo KY, et al. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14: 82–5
   Google Scholar
• Luo X, Kranzler HR, Zuo L, Wang S, Schork NJ, Gelernter J. Diplotype trend regression analysis of the ADH gene cluster and the ALDH2 gene: multiple significant associations with alcohol dependence. Am J Hum Genet 2006; 78: 973–87
   PubMedGoogle Scholar
• den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000; 15: 7–12
   PubMed Web of Science ®Google Scholar
• den Dunnen JT, Paalman MH. Standardizing mutation nomenclature: why bother?. Hum Mutat 2003; 22: 181–2
   PubMed Web of Science ®Google Scholar